Alaunos Therapeutics, Inc.
Public company- Headquarters
- FORT LAUDERDALE, Florida
- Ticker
- TCRT
- CIK
- 0001107421
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorPeter Harwin | Oct 13, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Polomar Health Services, Inc.
director departs: Alexandra Peterson
- Inhibitor Therapeutics, Inc.
Director appointed: Francis E. O’Donnell
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
director appointed: Peter Harwin
Peter Harwin was named director of Alaunos Therapeutics, Inc., effective October 13, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 13, 2026Role: director
- Executive departure
director departs: Robert W. Postma
Robert W. Postma, director of Alaunos Therapeutics, Inc., resigns the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 13, 2026Role: director
- Executive departure
director departs: Michael A. Jerman
Michael A. Jerman, director of Alaunos Therapeutics, Inc., resigns the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 13, 2026Role: director
- Executive departure
director departs: Jaime W. Vieser
Jaime W. Vieser, director of Alaunos Therapeutics, Inc., resigns the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 13, 2026Role: director
Last verified Nov 8, 2026